Pharmaceutical Executive, December 2016 Issue (PDF)

Five-year data from Phase III trials demonstrated that 67.7% of patients moderate-to-severe plaque psoriasis treated with UCB’s Bimzelx achieved complete skin clearance.

Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.

Dr. Hernan Bazan, CEO of South Rampart Pharma, discusses his company’s current pipeline.

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

The data analytics company based its new product on simple spreadsheet technology.

The latest news for pharma industry insiders.